Introduction {#s1}
============

Cytokinesis partitions the cytoplasm of the dividing cell. In non-plant eukaryotes, a contractile actomyosin ring strongly reduces the area of contact between the forming daughter cells. Consequently, little membrane expansion has to be supported by membrane traffic and fusion, which can largely be afforded by local recycling ([@bib13]). In contrast, dividing plant cells lack the contractile actomyosin ring and thus have to make a large partitioning membrane -- named cell plate -- which is progressively formed from the centre to the periphery of the cell ([@bib12]). The cell plate originates from membrane vesicles that fuse with one another upon delivery to the plane of cell division along the highly dynamic microtubules of the phragmoplast. Membrane fusion during *Arabidopsis* cytokinesis requires a cytokinesis-specific Qa-SNARE (aka syntaxin) named KNOLLE ([@bib7]), which forms two distinct functionally overlapping SNARE complexes by interaction with different sets of promiscuous SNARE partners: (i) QaQbcR-complex containing Qbc-SNARE SNAP33 and R-SNARE VAMP721 or VAMP722, and (ii) QaQbQcR-complex containing Qb-SNARE NPSN11, Qc-SNARE SYP71 and R-SNARE VAMP721 or VAMP722 ([@bib3]; [@bib4]; [@bib21]). The formation of these *trans*-SNARE complexes requires the cytokinesis-specific action of the Sec1/Munc18 (SM) protein KEULE, which interacts with monomeric KNOLLE but not with the assembled KNOLLE-containing SNARE complex at the plane of cell division ([@bib15]). It is not known in what form the SNARE proteins reside on the vesicles prior to the action of the SM protein. One possibility is that each SNARE protein is trafficked separately and kept in its monomeric form until fusion. Alternatively, one or more SNARE proteins might form inactive complexes. Or there might be a mixture of vesicles, some bearing the R-SNARE and others a preassembled Q-SNARE complex. Here, we examine in what form -- monomers or complexes -- SNARE proteins are present on the cytokinetic vesicles and where along the trafficking pathway complexes of cytokinetic SNARE proteins might be formed.

Results and discussion {#s2}
======================

The cytokinesis-specific Qa-SNARE KNOLLE is made during late G2/M phase and turned over rapidly at the end of cytokinesis ([@bib7]). Newly synthesised KNOLLE protein is inserted into the membrane of the endoplasmic reticulum (ER) and traffics along the secretory pathway via Golgi stack and *trans*-Golgi network (TGN) to the plane of cell division ([Figure 1A](#fig1){ref-type="fig"}) ([@bib16]). Upon cell-plate formation, KNOLLE is endocytosed and targeted via multivesicular body (MVB) to the vacuole for degradation ([Figure 1A](#fig1){ref-type="fig"}) ([@bib16]). Unlike the situation in mammals, yeast and most flowering plants, secretory traffic in *Arabidopsis* is insensitive to the fungal toxin brefeldin A (BFA). BFA inhibits the ARF-activating guanine-nucleotide exchange reaction of sensitive ARF-GEFs, thus preventing the formation of transport vesicles ([@bib10]; [@bib17]). We have engineered in *Arabidopsis* a BFA-inducible system with which secretory traffic can be blocked at two specific sites along the route, ER and TGN. Relevant BFA-insensitive ARF-GEFs, human GBF1-related GNL1 or human BIG1-related BIG3, were eliminated by mutation, leaving BFA-sensitive GNOM and BIG1,2,4, respectively ([@bib18], [@bib19]). Consequently, BFA treatment of *gnl1* mutant plants prevents recruitment of COPI coat complexes to the *cis*-Golgi membrane, causing collapse of the ER-Golgi traffic. Qa-SNARE KNOLLE is thus retained in the ER and cytokinesis is impaired, resulting in binucleate cells ([Figure 1A](#fig1){ref-type="fig"}) ([@bib18]). Late-secretory traffic from the TGN to the plane of cell division requires the formation of AP-1 complex-coated transport vesicles, which depends on the action of four functionally overlapping ARF-GEFs BIG1 to BIG4 ([@bib14]; [@bib19]). Mutational inactivation of the sole BFA-resistant ARF-GEF BIG3 renders AP-1 vesicle formation BFA-sensitive. KNOLLE is thus retained at TGN membrane aggregates called BFA compartments and cytokinesis is impaired, resulting in binucleate cells ([Figure 1A](#fig1){ref-type="fig"}) ([@bib19]). To examine in what form -- monomeric or part of complex -- KNOLLE is delivered to the plane of cell division, we inhibited secretory traffic by BFA treatment of *gnl1* and *big3* mutants. However, BFA treatment would inhibit secretory traffic in some dividing cells but not in others because the cells in the developing seedling root divide asynchronously. To overcome this limitation, we used β-estradiol (EST)-inducible expression of KNOLLE SNARE partners NPSN11 or SNAP33 fused to a fluorescent protein ([@bib22]). Importantly, neither YFP:NPSN11 nor GFP:SNAP33 was expressed without EST treatment ([Figure 1B--C](#fig1){ref-type="fig"}), which is a prerequisite for the detection of newly-made cytokinesis-specific SNARE complexes.10.7554/eLife.25327.002Figure 1.Site-specific inhibition of SNARE protein trafficking to the cell-division plane.(**A**) Qa-SNARE KNOLLE trafficking route in cytokinesis ([@bib16]). ER, endoplasmic reticulum; TGN, *trans*-Golgi network; CP, cell plate; MVB, multivesicular body; COPI, COPII, AP1/CCV, membrane vesicles with specific coat protein complexes; *gnl1*, *big3*, knockout mutations of ARF-GEFs rendering those trafficking steps sensitive to brefeldin A (BFA). (**B--D**) Subcellular localisation of estradiol-inducible YFP:NPSN11 (**B**, **D**; green) and GFP-SNAP33 (**C**, **D**; green), and KNOLLE (**B--D**; red) in *big3* (**B, C**) and *gnl1 GNL1^BFA-sens.^* (**D**) mutant seedling roots treated with 50 µM BFA for 30 min, followed by 50 µM BFA + 20 µM estradiol for 210 min. Note that YFP:NPSN11 (Y:N11) or GFP:SNAP33 (G:S33) accumulates with KNOLLE (KN) at the BFA compartments in BFA-treated *big3* mutant whereas YFP:NPSN11 or GFP:SNAP33 colocalises with KNOLLE at the ER in BFA-treated *gnl1 GNL1^BFA-sens.^* mutant. Note also no expression of YFP:NPSN11 (Y:N11, **B**) or GFP:SNAP33 (G:S33, **C**) without estradiol treatment. Nuclei of overlays (**B--D**) were counterstained with DAPI (blue). -BFA, mock treatment; +BFA, BFA treatment; -EST, no estradiol treatment. Arrowheads, cell plates; arrows, BFA compartments; asterisks, ER. Scale bar, 5 µm. The experiments were technically repeated three times.**DOI:** [http://dx.doi.org/10.7554/eLife.25327.002](10.7554/eLife.25327.002)10.7554/eLife.25327.003Figure 1---figure supplement 1.Cytokinetic cells in *big3* and *gnl1 GNL1^BFA-sens.^* mutant seedling roots.Mutant seedling roots were treated with 50 µM BFA for 30 min followed by 50 µM BFA + 20 µM estradiol for 210 min. Note that the population of cytokinetic cells was not altered by BFA treatment in mutant seedling roots, as evidenced by the anti-α-tubulin-labeled phragmoplast (red). See [supplementary file 1](#SD1-data){ref-type="supplementary-material"} for quantification. Nuclei were counterstained with DAPI (blue). WT, wild-type; -BFA, mock treatment; +BFA, BFA treatment. Arrowhead, cell-plate with phragmoplast. Scale bar, 25 µm. The experiments were technically repeated twice.**DOI:** [http://dx.doi.org/10.7554/eLife.25327.003](10.7554/eLife.25327.003)10.7554/eLife.25327.004Figure 1---figure supplement 2.Subcellular localisation (**A, B**) and co-immunoprecipitation analysis (**C**) of pKNOLLE::mRFP:PEP12 (aka SYP21) (red) in *big3* mutant seedling root cells expressing estradiol-inducible YFP:NPSN11 (**A, C**) and GFP:SNAP33 (**B, C**).Transgenic seedlings were treated with 50 µM BFA for 30 min followed by 50 µM BFA + 20 µM estradiol for 210 min. Protein extracts were subjected to immunoprecipitation with anti-GFP beads, protein blots were probed with the antisera indicated on the right (IB): GFP, anti-GFP; RFP, anti-RFP; KN, anti-KNOLLE; V721/V722, anti-VAMP721/722; SYP71, anti-SYP71. G:S33, GFP:SNAP33; R:P12, mRFP:PEP12; Y:N11, YFP:NPSN11. kDa, protein size (left); MW, molecular weight; -BFA, mock treatment; +BFA, BFA treatment; T, total extract; UB, unbound; IP, immunoprecipitate. Loading (%), relative loading volume to total volume; relative signal intensity (input signal = 100% for UB and IP). Nuclei of merged images (**A, B**) were counterstained with DAPI (blue). Arrowheads, cell plates; arrows, BFA compartments. Scale bar, 5 µm. The experiments were technically repeated three times.**DOI:** [http://dx.doi.org/10.7554/eLife.25327.004](10.7554/eLife.25327.004)10.7554/eLife.25327.005Figure 1---figure supplement 3.Site-specific inhibition of SNARE protein trafficking to the cell-division plane and loss of COPI from Golgi membrane in *gnl1 GNL1^BFA-sens.^* seedlings.Mutant seedling roots were treated with 50 µM BFA for 30 min, followed by 50 µM BFA + 20 µM estradiol for 210 min. Note cytosolic localisation of γCOP in BFA-treated cells whereas YFP:NPSN11 (Y:N11, **A**) and GFP:SNAP33 (G:S33, **B**) in the same condition were trapped in the ER. Nuclei of merged images were counterstained with DAPI (blue). -BFA, mock treatment; +BFA, BFA treatment. Arrowheads, cell plates; asterisks, ER. Scale bar, 5 µm. The experiments were technically repeated three times.**DOI:** [http://dx.doi.org/10.7554/eLife.25327.005](10.7554/eLife.25327.005)

Arabidopsis *big3* mutant seedlings were treated with BFA for 30 min followed by 210 min of combined BFA and EST treatment to induce expression of YFP:NPSN11 or GFP:SNAP33 in cells whose traffic to the cell-division plane was blocked at the TGN. Seedlings were then live-imaged for YFP:NPSN11 or GFP:SNAP33. The two fusion proteins accumulated in TGN-containing BFA compartments; this was in contrast to the strong labeling of cell plates in wild-type seedlings expressing BFA-resistant BIG3 ARF-GEF or in *big3* mutant seedlings not treated with BFA ([Figure 1B--C](#fig1){ref-type="fig"}). The frequency of cells undergoing cytokinesis was not altered by BFA treatment of wild-type or mutant seedlings, as evidenced by immunostaining of phragmoplast microtubules ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}; [Supplementary file 1a](#SD1-data){ref-type="supplementary-material"}).

Co-immunoprecipitation analysis of BFA-treated *big3* mutant seedlings expressing EST-inducible YFP:NPSN11 revealed the presence of Qb-SNARE NPSN11 fused to YFP, Qa-SNARE KNOLLE, Qc-SNARE SYP71 and R-SNARE VAMP721/722 as well as the absence of Qbc-SNARE SNAP33 in the anti-GFP precipitate ([Figure 2A](#fig2){ref-type="fig"}). Thus, only the members of the KNOLLE-NPSN11-SYP71-VAMP721/722 complex were co-immunoprecipitated whereas the SNARE partner SNAP33 from the other KNOLLE-containing SNARE complex was not. The converse was observed in the co-immunoprecipitation analysis of *big3* mutant seedlings expressing the EST-inducible Qbc-SNARE member of the other KNOLLE complex, GFP:SNAP33. Qc-SNARE SYP71 was not detected in the co-immunoprecipitate, in contrast to the members of the trimeric KNOLLE complex Qbc-SNARE GFP:SNAP33, Qa-SNARE KNOLLE and R-SNARE VAMP721/722 ([Figure 2B](#fig2){ref-type="fig"}). Thus, the interaction detected by co-immunoprecipitation was exclusively confined to members of the KNOLLE-containing complex that contained the EST-induced SNARE partner, strongly suggesting that only direct interactions between SNARE complex members were detected. Further co-immunoprecipitation experiments with non-EST-induced seedlings demonstrated that co-immunoprecipitation of KNOLLE indeed required the EST-induced expression of YFP:NPSN11 or GFP:SNAP33 ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). In addition, to rule out that these complexes might have formed during the immunoprecipitation procedure, we mixed the protein extracts with varying amounts of extract from *KNOLLE::mCherry:KNOLLE* transgenic seedlings before immunoprecipitation with anti-GFP beads. Neither 1x nor 10x mCherry:KNOLLE addition changed the amount of KNOLLE-containing SNARE complex formed ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). We also addressed whether BFA treatment might stimulate the formation of KNOLLE-containing SNARE complexes. To this end, we compared protein extracts from untreated wild-type seedlings with those from BFA-treated wild-type seedlings. No obvious difference in KNOLLE complex formation was detected between treated and untreated seedlings ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). As an additional control, we examined whether EST-induced KNOLLE-partners GFP:SNAP33 and YFP:NPSN11 co-immunoprecipitated the Qa-SNARE PEP12 (aka SYP21). PEP12 is normally located at the multivesicular body (MVB) ([@bib2]; [@bib11]), and was also relocated to the same BFA compartments as was YFP:NPSN11 in BFA-treated *big3* mutant seedlings ([Figure 1---figure supplement 2A--B](#fig1s2){ref-type="fig"}). Neither SNAP33 nor NPSN11 interacted with mRFP-tagged PEP12 whereas both did interact with KNOLLE, confirming the specificity of the co-immunoprecipitation assay ([Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}). These results indicate that KNOLLE forms part of a SNARE complex before the initiation of the fusion process at the plane of cell division. Thus, KNOLLE seems to be transported as part of two different *cis*-SNARE complexes from the TGN to the plane of cell division. These assembled SNARE complexes comprise either (i) KNOLLE, SNAP33 and VAMP721/722 or (ii) KNOLLE, NPSN11, SYP71 and VAMP721/722.10.7554/eLife.25327.006Figure 2.Interaction analysis of cytokinetic SNAREs with traffic blocked at the TGN.Wild-type (WT) and *big3* mutant seedlings carrying estradiol-inducible *YFP:NPSN11* (**A**) or *GFP:SNAP33* (**B**) transgenes were treated with 50 µM BFA for 30 min followed by 50 µM BFA + 20 µM estradiol for 210 min (see [Figure 1B--C](#fig1){ref-type="fig"}). Protein extracts were subjected to immunoprecipitation with anti-GFP beads, protein blots were probed with the antisera indicated on the right (IB): GFP, anti-GFP; KN, anti-KNOLLE; V721/V722, anti-VAMP721/722; SYP71, anti-SYP71; SNAP33, anti-SNAP33; kDa, protein size (left); MW, molecular weight; -BFA, mock treatment; +BFA, BFA treatment; T, total extract; UB, unbound; IP, immunoprecipitate. Loading (%), relative loading volume to total volume; relative signal intensity (input signal = 100% for UB and IP). The experiments were technically repeated more than six times.**DOI:** [http://dx.doi.org/10.7554/eLife.25327.006](10.7554/eLife.25327.006)10.7554/eLife.25327.007Figure 2---figure supplement 1.Control experiments for co-immunoprecipitation analysis of cytokinetic SNAREs.(**A**) No EST-induction of expression of KNOLLE SNARE partners. *big3* mutant seedlings carrying *YFP:NPSN11* (*left*) or *GFP:SNAP33* (*right*) transgenes were treated or not treated with 50 µM BFA for 240 min. Seedlings treated with 20 µM estradiol and 50 µM BFA for 210 min were used as positive control. Protein extracts were subjected to immunoprecipitation with anti-GFP beads, protein blots were probed with the antisera indicated on the right (IB). (**B**) In vitro mixing of experimental extract with different amounts of extract from tagged KNOLLE seedlings. Cleared protein extracts of YFP:N11 or GFP:SNAP33 and the cleared protein extracts of mCherry:KNOLLE were mixed and subjected to immunoprecipitation with anti-GFP beads. Protein blots were probed with the antisera indicated on the right (IB). Note that the addition of mCherry:KNOLLE protein does not alter the amount of endogenous KNOLLE co-immunoprecipitated with YFP:N11 or GFP:SNAP33. Non, no addition of mCherry:KNOLLE protein lysate; 1x, equal amounts; 10x, 10x excess. (**C**) Seedlings of wild-type (WT) background carrying *YFP:NPSN11* or *GFP:SNAP33* transgenes were treated with 50 µM BFA + 20 µM estradiol for 210 min. Protein extracts were subjected to immunoprecipitation with anti-GFP beads, protein blots were probed with the antisera indicated on the right (IB). GFP, anti-GFP; RFP, anti-RFP; KN, anti-KNOLLE; V721/V722, anti-VAMP721/722; kDa, protein size (left); MW, molecular weight; -EST, no estradiol; -BFA, mock treatment; +BFA, BFA treatment; T, total extract; UB, unbound; IP, immunoprecipitate; Loading (%), relative loading volume to total volume; relative signal intensity (input signal = 100% for UB and IP).**DOI:** [http://dx.doi.org/10.7554/eLife.25327.007](10.7554/eLife.25327.007)

To determine where along the secretory pathway the KNOLLE-containing *cis*-SNARE complexes are assembled, we blocked traffic already at the ER-Golgi interface by BFA treatment of *gnl1* mutant seedlings expressing engineered BFA-sensitive GNL1^BFA-sens.,^ ([@bib18]) and EST-inducible SNAREs YFP:NPSN11 or GFP:SNAP33. By subcellular localisation, all relevant SNARE components (YFP:NPSN11, GFP:SNAP33, KNOLLE) were detected at the ER ([Figure 1D](#fig1){ref-type="fig"}), indicating effective inhibition of traffic between ER and Golgi stacks. As an additional control, we analysed the subcellular localisation of COPI subunit γCOP, which is normally associated with the Golgi membrane whereas BFA treatment caused accumulation of γCOP in the cytosol ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}) ([@bib18]). Co-immunoprecipitation with anti-GFP beads of protein extracts from BFA-treated BFA-sensitive *GNL1^BFA-sens.^* seedlings revealed that KNOLLE already exists as part of a *cis*-SNARE complex in the ER. Further co-immunoprecipitation analysis demonstrated interactions exclusively between components within each cytokinetic SNARE complex but not between members of the two different SNARE complexes, ruling out recovery of non-interacting proteins from the same membrane compartment ([Figure 3A--B](#fig3){ref-type="fig"}). Thus, KNOLLE is trafficked in two different *cis*-SNARE complexes along the secretory pathway from the ER to the plane of cell division.10.7554/eLife.25327.008Figure 3.Interaction analysis of cytokinetic SNAREs with traffic blocked at the ER.Wild-type (WT) and *gnl1* mutant seedlings complemented with *GNL1^BFA-sens.^* encoding a BFA-sensitive variant of GNL1 and carrying estradiol-inducible *YFP:NPSN11* (**A**) or *GFP:SNAP33* (**B**) transgenes were treated with 50 µM BFA for 30 min followed by 50 µM BFA + 20 µM estradiol for 210 min (see [Figure 1D](#fig1){ref-type="fig"}). Protein extracts were subjected to immunoprecipitation with anti-GFP beads, protein blots were probed with the antisera indicated on the right (IB): GFP, anti-GFP; KN, anti-KNOLLE; V721/V722, anti-VAMP721/722; SYP71, anti-SYP71; SNAP33, anti-SNAP33; kDa, protein size (left); MW, molecular weight; -BFA, mock treatment; +BFA, BFA treatment; T, total extract; UB, unbound; IP, immunoprecipitate. Loading (%), relative loading volume to total volume; relative signal intensity (input signal = 100% for UB and IP). The experiments were technically repeated more than six times.**DOI:** [http://dx.doi.org/10.7554/eLife.25327.008](10.7554/eLife.25327.008)

Our results indicate that cytokinetic SNARE complexes are assembled on the ER and from there delivered as *cis*-SNARE complexes rather than monomeric SNARE proteins along the secretory pathway, via Golgi stack and TGN, to the plane of cell division ([Figure 4](#fig4){ref-type="fig"}). This implies that *cis*-SNARE complexes (i.e. residing on the same membrane) are delivered to the division plane where they are transformed into fusogenic *trans*-SNARE complexes linking adjacent membrane vesicles. These observations also explain the requirement for the SM protein KEULE during cell-plate formation ([@bib15]). Breaking up *cis*-SNARE complexes by the action of NSF ATPase, which normally occurs following the fusion of membrane vesicles with the target membrane ([@bib20]) would result in back-folding of the monomeric Qa-SNARE to prevent re-formation of the *cis*-SNARE complex. In cytokinesis, however, SM protein KEULE interacts with Qa-SNARE KNOLLE to keep it open as a prerequisite for the formation of the fusogenic *trans*-SNARE complex ([@bib15]).10.7554/eLife.25327.009Figure 4.Trafficking of *cis*-SNARE complexes during cytokinesis (model).Two different types of cytokinetic *cis*-SNARE complexes are assembled on the ER, recruited into COPII vesicles and passed on to the Golgi stack/TGN. At the TGN, they are incorporated into AP1/CCV vesicles for delivery to the division plane. Following their disassembly by NSF ATPase, monomeric Qa-SNARE KNOLLE is assisted by SM protein KEULE in the formation of *trans*-SNARE complexes mediating fusion of adjacent vesicles during cell-plate formation and expansion ([@bib15]).**DOI:** [http://dx.doi.org/10.7554/eLife.25327.009](10.7554/eLife.25327.009)

Trafficking of *cis*-SNARE complexes has two major advantages: (i) the *cis*-SNARE complex is an energetically favoured inactive form ([@bib5]) that is well-suited for transport and also ensures equal amounts of SNARE partners being delivered to the site of action. The four-helical bundle of the SNARE domains is very stable, requiring ATP hydrolysis for its disassembly. Because of its stability, the assembled *cis*-SNARE complex is physiologically inactive, not interacting with other SNARE proteins. (ii) Moreover, this might be a highly economic strategy of meeting the sharply rising demand for membrane-fusion capacity during cytokinesis when the equivalent of about one-third of the cell surface area has to be produced in the plane of cell division in a narrow time frame of about 30 min. In animal cytokinesis, the problem is largely solved by reducing the surface area through the constriction by the contractile ring that pulls in the plasma membrane. The remaining gap in the centre of the division plane is then closed by vesicle fusion that is mediated by plasma membrane SNARE proteins present throughout the cell cycle ([@bib8]) and/or by ESCRTIII activity ([@bib9]). Apart from plant cytokinesis, any major expansion of the eukaryotic cell surface area requires enhanced membrane fusion capacity that cannot easily be matched by the local recycling of plasma membrane-resident SNARE proteins whereas the long-distance delivery of inactive *cis*-SNARE complexes proposed here would meet the requirement.

Materials and methods {#s3}
=====================

Plant material, Growth Condition and Transformation {#s3-1}
---------------------------------------------------

*Arabidopsis thaliana* \[NCBITaxon:3702\] wild-type (Columbia, Col), *pKNOLLE::mCherry:KNOLLE* or mutant plants were grown on soil or media (1/2 MS medium, 0.1% MES, pH 5.6) at 23°C in continuous light condition. *big3* homozygous plants were transformed with *pMDC7::GFP:SNAP33* or *pMDC7::YFP:NPSN11* using *Agrobacterium* \[NCBITaxon:358\]-mediated floral dipping ([@bib1]; [@bib19]). T1 seedlings were selected on Hygromycin (20 µg/ml, Duchefa Biochemie, Netherlands) plates to isolate *big3* mutant plants carrying transgenes *pMDC7::GFP:SNAP33* or *pMDC7::YFP:NPSN11*. The same transgenes were introduced into a BFA-sensitive *GNL1* genetic background by crossing these transgenic plants with *gnl1* homozygous plants bearing a *pGNL1::GNL1^BFA-sens.^* transgene ([@bib18]). For interaction analysis of NPSN11 and SNAP33 with MVB-localised Qa-SNARE PEP12 (aka SYP21), *big3* homozygous plants bearing *pMDC7::GFP:SNAP33* or *pMDC7::YFP:NPSN11* were transformed with *pKNOLLE::mRFP:PEP12*. T1 plants were selected by spraying them three times with 1:1000 diluted BASTA (183 g/l glufosinate; AgrEvo, Düsseldorf, Germany). The homozygous background of *big3* or *gnl1 GNL1^BFA-sens.^* was confirmed as previously reported ([@bib18], [@bib19]).

Molecular biology {#s3-2}
-----------------

For generating *pMDC7::GFP:SNAP33, GFP:SNAP33* was amplified with GFP-AttB1-5 and SNAP33-AttB2-3 primers from *p35S::GFP:SNAP33* ([@bib15]). According to the manufacturer's instruction (Invitrogen, Molecular Probes), the PCR product was cloned into a modified β-estradiol inducible *pMDC7* vector ([@bib22]) in which *Ubiquitin 10* promoter replaced the original promoter (kindly provided by Niko Geldner, Univ. Lausanne). For generating *pMDC7::YFP:NPSN11*, *YFP:NPSN11* was amplified by PCR with YFP-AttB1-5 and NPSN11-AttB2-3 primers from *pKNOLLE::YFP:NPSN11* ([@bib3]) and further cloned into the same *pMDC7* vector as described above. For generating *pKNOLLE::mRFP:PEP12*, *PEP12* coding sequence was amplified by PCR with PEP12-XbaI-5 and PEP12-EcoRI-3 primers. The PCR products were digested with *Xba*I and *Eco*RI (Thermo Fischer Scientific, Massachusetts, US) and cloned in-frame downstream of *mRFP* in the *KNOLLE* expression cassette ([@bib11]). For primer sequences, see [supplementary file 1b](#SD1-data){ref-type="supplementary-material"}.

Chemical treatment {#s3-3}
------------------

Five-day-old seedlings grown on solid media (1/2 MS, 0.1% MES, pH 5.6, 0.9% Agar) were transferred to liquid media (1/2 MS, 0.1% MES, 1% sucrose, pH 5.6) with or without 50 µM brefeldin A (BFA, 50 mM stock solution in 1:1 DMSO/EtOH, Invitrogen). After 30 min, 20 µM β-estradiol (EST, 20 mM stock solution in DMSO, Sigma-Aldrich, St. Louis, US) was added, and the seedlings were then incubated for another 210 min with mild agitation.

Co-immunoprecipitation and immunoblot analysis {#s3-4}
----------------------------------------------

Co-immunoprecipitation was slightly modified from a published protocol ([@bib15]). In brief, 1--2 g of seedlings were frozen in liquid nitrogen (N~2~) immediately after chemical treatment. The seedlings were thoroughly grounded and the powder suspended in ice-cold buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.5% Triton X-100) supplemented with EDTA-free complete protease inhibitor cocktail (Roche, Basel, Swiss Confederation). Cleared protein lysate was incubated with anti-GFP beads (GFP-trap, Chromotek, Planegg-Martinsried, Germany) for 2 hr in the cold room with mild rotation. The beads were washed six times with ice-cold buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.2% Triton X-100) supplemented with EDTA-free complete protease inhibitors cocktail and resuspended with 2x Laemmli buffer. For [Figure 2---figure supplements 1B](#fig2s1){ref-type="fig"}, 0.3 ml of cleared protein extracts of YFP:N11 or GFP:SNAP33 were incubated with 0.3 ml or 3 ml of the cleared protein extracts of mCherry:KNOLLE for 2 hr as described above and subjected to immunoprecipitation with anti-GFP beads. For immunoblot analysis, primary antisera anti-GFP (1:1000, mouse, Roche \[SCR:001326\]), anti-KNOLLE (KN, 1:6000, rabbit) ([@bib7]), anti-VAMP721/VAMP722 (V721/V722) (1:5000, rabbit) ([@bib6]), anti-SNAP33 (1:5000, rabbit) ([@bib4]), anti-SYP71 (1:4000, rabbit) ([@bib3]), anti-RFP (1:700, rat, Chromotek \[RRID:[AB_2336064](https://scicrunch.org/resolver/AB_2336064)\]), anti-γCOP (aka SEC21) (1:5000, rabbit, Agrisera, Vännäs, SWEDEN \[SCR:013574\]) and POD-conjugated secondary antibodies (1:5000 for anti-rabbit-POD, 1:2000 for anti-rat-POD, Sigma-Aldrich \[SCR:008988\]) were used. Membranes were developed using a chemiluminescence detection system (Fusion Fx7 Imager, PEQlab, Erlangen, Germany).

Immunofluorescence analysis {#s3-5}
---------------------------

After chemical treatment, seedlings were immediately fixed in 4% (w/v) paraformaldehyde for 1 hr and stored at −20°C until used for immunostaining. For immunofluorescence, primary antisera anti-KN (1:4000, rabbit) ([@bib7]), anti-γCOP (1:2000, rabbit, Agrisera), anti-α-tubulin (1:600, rat, Abcam, Cambridge, UK \[SCR:012931\]) and secondary antibodies anti-rabbit Cy3 (1:600, Dianova, Hamburg, Germany), anti-rat Cy3 (1:600, Dianova) were applied. Nuclei were stained with 1 µg/ml DAPI (1 mg/ml stock solution in H~2~O). Samples were prepared manually or with an immunohistochemistry system (InsituPro VSi, Intavis, Cologne, Germany). Fluorescent images were taken using a confocal laser scanning microscope (Leica SP8 for [Figure 1](#fig1){ref-type="fig"} and [Figure 1---figure supplements 1](#fig1s1){ref-type="fig"} and [2](#fig1s2){ref-type="fig"}; Zeiss LSM880 for [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}).

Softwares {#s3-6}
---------

Sequences were analysed with CLC main workbench 6. Fluorescent images were maximally projected from Z-stack images using the Fiji ImageJ program. Images were further processed using Adobe Photoshop CS3 and Adobe Illustrator CS3. For quantifying signal intensity in immunoblot analysis, the Fiji (ImageJ, NIH) program was used.
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Mohan K

Reviewing editor
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"ER assembly of SNARE complexes mediating formation of partitioning membrane in Arabidopsis cytokinesis\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Mohan Balsubramanian as Reviewing Editor and Christian Hardtke as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Jürgen Kleine-Vehn (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The referees agreed that your work uncovers novel mechanisms of how SNARE proteins are held in an inactive state after assembly at the ER and potentially how these may be activated. The use of a combination of approaches including genetics, imaging, biochemistry, and inhibitor studies was also appreciated. However, a few issues have been raised, all of which should be possible to be accomplished with the tools already available in your laboratory.

Essential revisions:

1\) The possibility that SNARE molecules could assemble into the complexes during procedures of immunoprecipitation should be ruled out. It would be effective to add excessive amounts of purified proteins of or plant lysates containing KNOLLE and/or VAMP721 with specific tags into the reactions to show the exogenous proteins do not affect the amounts of the SNARE complexs.

2\) The immunoprecipitation experiments should be also accompanied by control using non-induced plants, Y:N11 and G:S33 plants without the EST treatment, which is useful to firmly show that authors detected only de-novo-synthesized proteins.

3\) It will be interesting to know if Keule is present in any of your GFP immune complexes, given its important role in cell plate formation.

4\) The entire manuscript is based on drug treatments and it remains a possibility that BFA induces certain identity changes to the compartments or cytokinetic cells. Hence, the drug itself could actually stimulate complex assembly, which may not occur in its absense. It would be very nice if the authors could show the SNARE complexes at the ER in the absence of BFA. There are possibly several possibilities to follow, but overexpression of SEC12 could for example retain the SNARE complex in a drug free manner.
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Author response

*Essential revisions:*

*1) The possibility that SNARE molecules could assemble into the complexes during procedures of immunoprecipitation should be ruled out. It would be effective to add excessive amounts of purified proteins of or plant lysates containing KNOLLE and/or VAMP721 with specific tags into the reactions to show the exogenous proteins do not affect the amounts of the SNARE complexs.*

This criticism questions the general reliability of co-immunoprecipitation (co-IP) experiments, which are believed to reveal protein-protein interactions that occur in the living cell before its destruction.

In our study, we took care to reveal specific interactions by using two relevant controls:

1\) KNOLLE forms 2 different SNARE complexes, as reported by us before (El Kasmi et al., 2013,): (i) KNOLLE, NPSN11, SYP71, VAMP721/722; (ii) KNOLLE, SNAP33, VAMP721/722. Furthermore, we have shown that those two complexes both contribute to cell plate formation. By immunoprecipitating the member of one complex (e.g. YFP-NPSN11) we co-immunoprecipitated other SNARE partners from the same KNOLLE complex (e.g. SYP71) but not a member of the other complex (e.g. SNAP33) and vice versa.

2\) We also checked for the presence of the endosomal syntaxin (aka Qa-SNARE) PEP12 (aka SYP21) in the precipitate, again a negative result. Thus, we can exclude the possibility that our extraction procedure might disrupt selective protein-protein interactions and/or might lead to false positive signals because of insufficient solubilisation of the membranes on which the SNARE proteins reside. We hope that these controls are sufficient to demonstrate specificity of SNARE interaction in our co-IP experiments.

We would like to mention yet another evidence for the reliability of our co-IP procedure. We have reported that the linker sequence of KNOLLE is a binding site for the regulatory SEC1-like SM protein, KEULE, as shown by yeast two-hybrid assay and co-immunoprecipitation (Park et al., 2012). In that experiment, only KNOLLE was co-immunoprecipitated with HA-KEU but not tagged KNOLLE lacking its authentic linker sequence. Furthermore, the constitutively active form of KNOLLE was not co-immunoprecipitated with HA-KEU in the same experimental condition. These findings essentially rule out the possibility of non-specific assembly of SNARE complexes during protein preparation under our experimental conditions.

Due to limited material, we have used KN::mCherry:KNOLLE rather than KN::Myc-KN. We have performed the mixing experiment as proposed by adding to the experimental extract the same amount or 10x the amount of extract from *KN::mCherry-KN* transgenic seedlings before immunoprecipitation with anti-GFP beads. The results are shown in a new [Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"} and mentioned in the text as follows: \"In addition, to rule out that these complexes might have formed during the immunoprecipitation procedure, we mixed the protein extracts with varying amounts of extract from *KN::mCherry:KNOLLE* transgenic seedlings before immunoprecipitation with anti-GFP beads. Neither 1x nor 10x mCherry:KNOLLE addition changed the amount of KNOLLE-containing SNARE complex formed ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"})\".

*2) The immunoprecipitation experiments should be also accompanied by control using non-induced plants, Y:N11 and G:S33 plants without the EST treatment, which is useful to firmly show that authors detected only de-novo-synthesized proteins.*

We showed images of non-induced seedling root cells in which the KNOLLE signal was present at the cell plate but no signal of YFP-NPSN11 or GFP-SNAP33 was detectable ([Figure 1B, C](#fig1){ref-type="fig"}).

We have performed the control experiments proposed, and the results of the immunoprecipitation analysis of non-induced seedlings are shown in a new panel to [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"} and referred to in the text as follows: \"Further co-immunoprecipitation experiments with non-EST-induced seedlings demonstrated that co-immunoprecipitation of KNOLLE indeed required the EST-induced expression of YFP:NPSN11 or GFP:SNAP33 ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}) (comment \#2).\" Because the co-IP experiment covers the Western blot analysis of total protein extract proposed above the latter has been omitted.

*3) It will be interesting to know if Keule is present in any of your GFP immune complexes, given its important role in cell plate formation.*

We have shown before that SEC1-like SM protein KEULE only interacts with monomeric KNOLLE, but not with the assembled KNOLLE complexes (using co-IP as well as pull-down from lysate with recombinant proteins). In addition, KEULE and KNOLLE only meet at the cell plate, but not prior to their arrival at that site (Park et al., 2012). When trafficking is blocked with BFA, KEULE still gets to the plane of division. Consistently, KEULE is not required for targeting of KNOLLE to the cell plate, and KNOLLE is not required for KEULE to get to the division plane (Waizenegger et al., Curr. Biol. 10, 1371; Park et al., 2012).

*4) The entire manuscript is based on drug treatments and it remains a possibility that BFA induces certain identity changes to the compartments or cytokinetic cells. Hence, the drug itself could actually stimulate complex assembly, which may not occur in its absense. It would be very nice if the authors could show the SNARE complexes at the ER in the absence of BFA. There are possibly several possibilities to follow, but overexpression of SEC12 could for example retain the SNARE complex in a drug free manner.*

We admit that there is a theoretical possibility that BFA might stimulate complex assembly. However, we consider this highly unlikely because of our several years of experience with BFA interference of membrane trafficking. The primary target of BFA has been identified as the SEC7 domain of ARF-GEFs in yeast and in Arabidopsis, and in both systems, BFA-sensitive ARF-GEFs have been rendered BFA-resistant. By rendering all three yeast ARF-GEFs (Gea1, Gea2, Sec7) BFA-resistant, yeast was enabled to grow on BFA-containing medium, indicating that there are no other essential BFA targets in yeast (Peyroche et al., 1999, Mol Cell 3, 275-285). We have also rendered BFA-sensitive ARF-GEFs BFA-resistant and vice versa by introducing single amino acid residue changes (M to L or L to M) (Geldner et al., 2003, Cell 112, 219-230; Richter et al., 2007; Richter et al., 2011, Nat Cell Biol 14, 80-86; Richter et al., 2014). In addition, the structure of the SEC7 domain complexed with the GDP-GTP exchange inhibitor BFA has been resolved (Mossessova et al., 2003; Renault et al., 2003). From a functional perspective, we have shown that BFA treatment resulting in BFA compartments can selectively effect either non-polar secretion of newly-synthesised auxin-efflux carrier PIN1 or the polar recycling of PIN1, depending on which of the endosomal ARF-GEFs, BIG3 or GNOM is (rendered) BFA-resistant (Richter et al., 2014). This specific example clearly demonstrates that the specific BFA-sensitive ARF-GEF(s) determines the physiological outcome of BFA treatment.

To address the possibility that BFA itself might stimulate SNARE complex assembly, we compared SNARE complex formation in BFA-treated with non-treated wild-type seedlings that expressed YFP-NPSN11 or GFP-SNAP33 by immunoprecipitation with anti-GFP beads. The results are shown as a new panel to [Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"} and mentioned in the text as follows: \"We also addressed whether BFA treatment might stimulate the formation of KNOLLE-containing SNARE complexes. To this end, we compared protein extracts from untreated wild-type seedlings with those from BFA-treated wild-type seedlings. No obvious difference in KNOLLE complex formation was detected between treated and untreated seedlings ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"})\".

[^1]: These authors contributed equally to this work.
